MELA Sciences Inc Share Price Nasdaq
Equities
US55277R1005
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2024 * | 31.16M 2.4B | Sales 2025 * | 33.82M 2.6B | Capitalization | 11.43M 879M |
---|---|---|---|---|---|
Net income 2024 * | -10M -769M | Net income 2025 * | -5M -384M | EV / Sales 2024 * | 0.37 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.34 x |
P/E ratio 2024 * |
-1.11
x | P/E ratio 2025 * |
-2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.41% |
Latest transcript on MELA Sciences Inc
Managers | Title | Age | Since |
---|---|---|---|
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 09/04/18 |
Director of Finance/CFO | 42 | 05/07/21 | |
Shmuel Gov
COO | Chief Operating Officer | - | 31/12/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Uri Geiger
CHM | Chairman | 56 | 28/05/18 |
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 09/04/18 |
Director/Board Member | 60 | 28/05/18 |
1st Jan change | Capi. | |
---|---|---|
+4.57% | 212B | |
+8.61% | 187B | |
+26.34% | 155B | |
+33.90% | 115B | |
+2.17% | 65.5B | |
+14.50% | 52.87B | |
-3.30% | 45.25B | |
-3.98% | 39.7B | |
+6.66% | 37.72B |